The DOI matches its Crossref record; 15 of the 23 references it cites were found in a registry or an index, and 8 are not checked yet.
Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy
Abstract
Purpose: The incidence of prostate cancer is frequent, occurring in almost one-third of men older than 45 years. Only a fraction of the cases reach the stages displaying clinical significance. Despite the advances in our understanding of prostate carcinogenesis and disease progression, our knowledge of this disease is still fragmented. Identification of the genes and patterns of gene expression will provide a more cohesive picture of prostate cancer biology. Patients and Methods: In this study, we performed a comprehensive gene expression analysis on 152 human samples including prostate cancer tissues, prostate tissues adjacent to tumor, and organ donor prostate tissues, obtained from men of various ages, using the Affymetrix (Santa Clara, CA) U95a, U95b, and U95c chip sets (37,777 genes and expression sequence tags). Results: Our results confirm an alteration of gene expression in prostate cancer when comparing with nontumor adjacent prostate tissues. However, our study also indicates that the gene expression pattern in tissues adjacent to cancer is so substantially altered that it resembles a cancer field effect. Conclusion: We also found that gene expression patterns can be used to predict the aggressiveness of prostate cancer using a novel model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,575
Classical and Modern Regression With Applications.
Steinhorst, R. K., & Myers, R. H. (1988) · Journal of the American Statistical Association · doi:10.2307/2288958 · Cited by 3,690
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Gene expression correlates of clinical prostate cancer behavior
Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00030-2 · Cited by 2,512
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang‐Rodriguez, J., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M. (2001) · PubMed · Cited by 856
Latulippe, É., Satagopan, J. M., Smith, A., Scher, H. I., Scardino, P. T., Reuter, V. E., & Gerald, W. L. (2002) · PubMed · Cited by 518
Cited by
Items 501–600 of 761
Kanaoka, S., Okabe, A., Kanesaka, M., Rahmutulla, B., Fukuyo, M., Seki, M., Hoshii, T., Sato, H., Imamura, Y., Sakamoto, S., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216815 · Cited by 13
Zhang, J., Wilkinson, J. E., Gonit, M., Keck, R. W., Selman, S. H., & Ratnam, M. (2008) · The Prostate · doi:10.1002/pros.20779 · Cited by 13
Yang, L., Zhang, J., Yang, G., Xu, H., Lin, J., Shao, L., Li, J., Guo, C., Du, Y., Guo, L., et al. (2020) · Theranostics · doi:10.7150/thno.44229 · Cited by 13
Immunogenomic Profiling and Classification of Prostate Cancer Based on HIF-1 Signaling Pathway
Song, J., Chen, W., Zhu, G., Wang, W., Sun, F., & Zhu, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01374 · Cited by 13
Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer.
Oh, S., Shin, S., & Janknecht, R. (2021) · International Journal of Clinical and Experimental Pathology · Cited by 13
Analyzing biomarker discovery: Estimating the reproducibility of biomarker sets
Forouzandeh, A., Rutar, A., Kalmady, S., & Greiner, R. (2021) · bioRxiv · doi:10.1371/journal.pone.0252697 · Cited by 13
Huang, J., Liu, W., Zhang, D., Lin, B., & Li, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1023455 · Cited by 18
Gong, Y., Wang, L., Chippada-Venkata, U., Dai, X., Oh, W. K., & Zhu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11925 · Cited by 13
Sheetz, T. J., Mills, J., Tessari, A., Pawlikowski, M., Braddom, A. E., Posid, T., Zynger, D. L., James, C. L., Embrione, V., Parbhoo, K., et al. (2020) · Cancers · doi:10.3390/cancers12071861 · Cited by 13
Inference of combinatorial Boolean rules of synergistic gene sets from cancer microarray datasets
Park, I. H., Lee, K. H., & Lee, D. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq207 · Cited by 15
Modeling human prostate cancer progression in vitro
Liu, T. T., Ewald, J. A., Ricke, E. A., Bell, R. H., Collins, C. C., & Ricke, W. A. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy185 · Cited by 13
Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model
Vasiliauskas, J., Nashu, M. A., Pathrose, P., Starnes, S. L., & Waltz, S. E. (2014) · Oncotarget · doi:10.18632/oncotarget.2139 · Cited by 13
Ren, C., Chen, X., Hao, X., Wu, C., Xie, L., & Liu, X. (2024) · Scientific Data · doi:10.1038/s41597-024-03551-2 · Cited by 13
Subramaniam, S., Jeet, V., Gunter, J. H., Janjua, T. I., Feng, Y., Clements, J. A., Srinivasan, S., Popat, A., & Batra, J. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217522 · Cited by 13
Representation of a Fisher Criterion Function in a Kernel Feature Space
Lee, S. W., & Bien, Z. (2009) · IEEE Transactions on Neural Networks · doi:10.1109/tnn.2009.2036846 · Cited by 12
The context of prostate cancer genomics in personalized medicine
Liu, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.5911 · Cited by 14
Higgins, J., Brogley, M. A., Palanisamy, N., Mehra, R., Ittmann, M., Li, J. Z., Tomlins, S. A., & Robins, D. M. (2015) · Hormones and Cancer · doi:10.1007/s12672-014-0215-9 · Cited by 12
Partition decoupling for multi-gene analysis of gene expression profiling data
Braun, R., Leibon, G., Pauls, S. D., & Rockmore, D. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-497 · Cited by 16
Amplification of the 9p13.3 chromosomal region in prostate cancer
Latonen, L., Leinonen, K. A., Grönlund, T., Vessella, R. L., Tammela, T. L. J., Saramäki, O. R., & Visakorpi, T. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22364 · Cited by 12
Long noncoding RNA MIR22HG is down-regulated in prostate cancer
Shen, H., Weng, X., Du, Y., Wang, L., Liu, X., & work, †. T. A. C. E. T. T. (2020) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2020093 · Cited by 12
Tolkach, Y., Kuczyk, M. A., & Imkamp, F. (2014) · European Urology · doi:10.1016/j.eururo.2014.08.002 · Cited by 12
Computational Tools for Parsimony Phylogenetic Analysis of Omics Data
Salazar, J., Amri, H., Noursi, D., & Abu-Asab, M. S. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0018 · Cited by 11
Stoss, O., Werther, M., Zielinski, D., Middel, P., Jost, N., Rüschoff, J., Henkel, T. O., & Albers, P. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4501001 · Cited by 11
Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer
Goh, L. K., Liem, N. L. M., Vijayaraghavan, A., Chen, G., Lim, P. L., Tay, K. J., Chang, M., Low, J. S. W., Joshi, A., Huang, H. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091666 · Cited by 11
Using Molecular Markers to Help Predict Who Will Fail after Radical Prostatectomy
Swanson, G. P., & Quinn, D. I. (2011) · Prostate Cancer · doi:10.1155/2011/290160 · Cited by 11
Coordinate MicroRNA-Mediated Regulation of Protein Complexes in Prostate Cancer
Alshalalfa, M., Bader, G. D., Bismar, T. A., & Alhajj, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084261 · Cited by 11
Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer
Kido, T., Schubert, S., Hatakeyama, S., Οhyama, C., Schmidtke, J., & Lau, Y. C. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-9 · Cited by 12
Yes-Associated Protein Expression Is Correlated to the Differentiation of Prostate Adenocarcinoma
Noh, M., Kim, S. S., Hwang, E. C., Kwon, D. D., & Choi, C. (2017) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2017.05.04 · Cited by 11
Rocha, S. M., Socorro, S., Passarinha, L. A., & Maia, C. J. (2022) · Data · doi:10.3390/data7050064 · Cited by 14
Bax and Bcl-2 are focally overexpressed in the normal epithelium of cancerous prostates
Tolonen, T. T., Tommola, S., Jokinen, S., Parviainen, T., & MARTIKAINEN, P. M. (2007) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590601181257 · Cited by 11
Bhattacharya, A., Chowdhury, N., & De, R. K. (2012) · Current Bioinformatics · doi:10.2174/157489312799304440 · Cited by 11
Identification of prostate cancer modifier pathways using parental strain expression mapping
Xu, Q., Majumder, P. K., Ross, K. N., Shim, Y., Golub, T. R., Loda, M. F., & Sellers, W. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708476104 · Cited by 11
Applications of gene pair methods in clinical research: advancing precision medicine
Wu, C., Xie, X., Yang, X., Du, M., Lin, H., & Huang, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00263-w · Cited by 10
“In their study, the authors collected and integrated approximately 1500 microarray gene expression profiles from 26 published cancer datasets, involving 21 major human cancer types (including lung, breast, bladder, ovary, pancreas, etc.) [108–110].”
Module-based prediction approach for robust inter-study predictions in microarray data
Mi, Z., Shen, K., Song, N., Cheng, C., Song, C., Kaminski, N., & Tseng, G. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq472 · Cited by 10
Watson, S. K., Woolcock, B. W., Fee, J., Bainbridge, T. C., Webber, D. L., Κinahan, T. J., Lam, W. L., & Vielkind, J. R. (2009) · The Prostate · doi:10.1002/pros.20949 · Cited by 10
Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review
Chen, Z., Gerke, T. A., Bird, V. Y., & Prosperi, M. (2017) · Biomedicine Hub · doi:10.1159/000472146 · Cited by 10
Fully moderated t-statistic in linear modeling of mixed effects for differential expression analysis
Yu, L., Zhang, J., Brock, G. N., & Fernández, S. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3248-9 · Cited by 12
Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets
Spethmann, T., Boeckelmann, L., Labitzky, V., Ahlers, A., Schröder‐Schwarz, J., Bonk, S., Simon, R., Sauter, G., Huland, H., Kypta, R. M., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12922 · Cited by 10
Liu, S., Huang, D., Huang, J., Yan, J., Chen, T., Zhang, N., Jiang, G., Gao, Y., Xu, D., & Na, R. (2021) · Journal of Cancer · doi:10.7150/jca.50299 · Cited by 10
Distribution-free tests of mean vectors and covariance matrices for multivariate paired data
Li, E., Lim, J., Kim, K., & Lee, S. (2011) · Metrika · doi:10.1007/s00184-011-0355-7 · Cited by 10
Curation-free biomodules mechanisms in prostate cancer predict recurrent disease
Chen, J. L., Hsu, A., Yang, X. H., Li, J., Lee, Y., Parinandi, G., Li, H., & Lussier, Y. A. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s2-s4 · Cited by 10
Tsoi, L. C., Qin, T., Slate, E. H., & Zheng, W. J. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-438 · Cited by 10
Advances in microfluidic platforms for tumor cell phenotyping: from bench to bedside
Joshi, R., Ahmadi, H., Gardner, K., Bright, R. K., Wang, W., & Li, W. (2025) · Lab on a Chip · doi:10.1039/d4lc00403e · Cited by 9
BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer
Roganowicz, M., Bär, D., Bersaglieri, C., Aprigliano, R., & Santoro, R. (2023) · Life Science Alliance · doi:10.26508/lsa.202301950 · Cited by 9
Tumor cell group via phospholipase A2 is involved in prostate cancer development
Li, H., Zhang, H., Wei, G., Cai, Q., Yan, L., & Xu, Y. (2010) · The Prostate · doi:10.1002/pros.21251 · Cited by 9
Activin B and Activin C Have Opposing Effects on Prostate Cancer Progression and Cell Growth
Reader, K. L., John-McHaffie, S., Zellhuber-McMillan, S., Jowett, T. W. D., Mottershead, D. G., Cunliffe, H. E., & Gold, E. (2022) · Cancers · doi:10.3390/cancers15010147 · Cited by 9
Li, G., Li, M., Zhang, Y., Wang, D., Li, R., Guimerà, R., Gao, J. T., & Zhang, M. Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094608 · Cited by 10
Zycinski, G., Barla, A., Squillario, M., Sanavia, T., Camillo, B. D., & Verri, A. (2013) · Source Code for Biology and Medicine · doi:10.1186/1751-0473-8-2 · Cited by 9
Roles of the HOXA10 gene during castrate-resistant prostate cancer progression
Long, Z., Li, Y., Gan, Y., Zhao, D., Wang, G., Xie, N., Lovnicki, J. M., Fazli, L., Cao, Q., Chen, K., et al. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0465 · Cited by 9
TBX1 Functions as a Tumor Activator in Prostate Cancer by Promoting Ribosome RNA Gene Transcription
Cui, J., Zhang, Y., Ren, X., Jin, L., & Zhang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.616173 · Cited by 9
A Systems Approach to Model Metastatic Progression
Taylor, B. S., Varambally, S., & Chinnaiyan, A. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0415 · Cited by 9
Alioui, A., Dufour, J., Leoni, V., Loregger, A., Moeton, M., Iuliano, L., Zerbinati, C., Septier, A., Val, P., Fouache, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00508-5 · Cited by 8
RetractedLong, X., Wu, L., Zeng, X., Wu, Z., Hu, X., Jiang, H., Lv, Z., Yang, C., Cai, Y., Yang, K., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3419 · Cited by 8
Klümper, N., von Danwitz, M., Stein, J., Schmidt, D. H., Schmidt, A., Kristiansen, G., Muders, M. H., Hölzel, M., Ritter, M., Alajati, A., et al. (2020) · Cancers · doi:10.3390/cancers12113439 · Cited by 8
Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer
Gerke, T. A., Beltran, H., Wang, X., Lee, G. M., Sboner, A., Karnes, R. J., Klein, E. A., Davicioni, E., Yousefi, K., Ross, A. E., et al. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0667 · Cited by 8
Identification of Novel Markers of Prostate Cancer Progression, Potentially Modulated by Vitamin D
Caltabiano, R., Castrogiovanni, P., Barbagallo, I. A., Ravalli, S., Szychlinska, M. A., Favilla, V., Schiavo, L., Imbesi, R., Musumeci, G., & Rosa, M. D. (2019) · Applied Sciences · doi:10.3390/app9224923 · Cited by 8
Rye, M. B., Krossa, S., Hall, M., van Mourik, C., Bathen, T. F., Drabløs, F., Tessem, M., & Bertilsson, H. (2022) · iScience · doi:10.1016/j.isci.2022.104451 · Cited by 9
Gu, Y., Li, S., QIU, X., & Wang, E. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.00918.x · Cited by 8
Alinezhad, S., Väänänen, R., Mattsson, J., Li, Y., Tallgrén, T., Tong-Ochoa, N., Bjartell, A. S., Åkerfelt, M., Taimen, P., Boström, P. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158255 · Cited by 8
The role of NOP58 in prostate cancer progression through SUMOylation regulation and drug response
Guo, W., Zong, S., Liu, T., Chao, Y., & Wang, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1476025 · Cited by 7
HALVORSEN, O. J. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.0s123.x · Cited by 8
Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility
Kuo, T.-C., Tan, C., Chang, Y.-W., Hong, C., Lee, W.-J., Chen, M.-W., Jeng, Y., Chiou, J., Yu, P., Chen, P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91882 · Cited by 8
Screening and identification of key biomarkers in prostate cancer using bioinformatics
Li, S., Hou, J., & Xu, W. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10799 · Cited by 7
Role of Opiorphin Genes in Prostate Cancer Growth and Progression
Mukherjee, A., Park, A., Wang, L., & Davies, K. P. (2021) · Future Oncology · doi:10.2217/fon-2020-1299 · Cited by 8
Novel Biomarkers for Prostate Cancer Revealed by (α,β)-k-Feature Sets
Ravetti, M. G., Berretta, R. E., & Moscato, P. (2009) · Studies in computational intelligence · doi:10.1007/978-3-642-01536-6_7 · Cited by 7
ELIMINATING THE CURRENT BELL CURVE TO IMPROVE THE RESULTS OF RADICAL PROSTATECTOMY
Nelson, J. B. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000163780.93013.6a · Cited by 7
Self-citationA harmonized resource of integrated prostate cancer clinical, -omic, and signature features
Laajala, T. D., Sreekanth, V., Soupir, A. C., Creed, J. H., Halkola, A. S., Calboli, F. C. F., Singaravelu, K., Orman, M. V., Colin, C., Gerke, T. A., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02335-4 · Cited by 8
Lin, Y., Wang, R., Li, F., Lu, Z., Luo, W., Lu, H., Xu, Z., Xu, C., Lu, Y., Zhu, Z., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2504904123 · Cited by 6
Pan-cancer network disorders revealed by overall and local signaling entropy
Feng, L., Sun, Y., Li, C., Li, Y., Chen, L., & Zeng, R. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab031 · Cited by 6
Potential role for protein kinase D inhibitors in prostate cancer
Chalfant, V., Riveros, C. A., Singh, P. K., Shukla, S., Balaji, N., & Balaji, K. C. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02298-4 · Cited by 6
Ratnam, M., Patki, M., Gonit, M., & Trumbly, R. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_6 · Cited by 6
Zhang, W., Li, T., & Lin, S. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105559 · Cited by 6
ATP8B1 : A prognostic prostate cancer biomarker identified via genetic analysis
Chen, L., Huang, S., Shih, C., Li, C., Chen, Y., Huang, C., Yu, C., Lin, V. C.-H., Lee, C., Geng, J., et al. (2023) · The Prostate · doi:10.1002/pros.24495 · Cited by 6
Balraj, A. S., Muthamilselvan, S., Raja, R., & Palaniappan, A. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231222389 · Cited by 7
Current management of prostate cancer: dilemmas and trials
Brown, C. O., & Waxman, J. H. (2012) · British Journal of Radiology · doi:10.1259/bjr/13017671 · Cited by 6
Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology
Farashi, S., Kryza, T., & Batra, J. (2020) · Genes · doi:10.3390/genes11050526 · Cited by 6
Liu, Y., Song, H., Pan, J., & Zhao, J. (2013) · Journal of Applied Genetics · doi:10.1007/s13353-013-0174-9 · Cited by 6
RetractedActin and Actin-Binding Proteins in Cancer Progression and Metastasis
Troys, M. V., Vandekerckhove, J. S., & Ampè, C. (2008) · Springer eBooks · doi:10.1007/978-0-387-71749-4_10 · Cited by 6
Stylianou, N., Lehman, M., Wang, C., Fard, A. T., Rockstroh, A., Fazli, L., Jovanovic, L., Ward, M. S., Sadowski, M. C., Kashyap, A. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0587-3 · Cited by 6
Lin, J., Chen, Z., Li, Z., Nong, D., Li, X., Huang, G., Hao, N., Liang, J., & Li, W. (2021) · Oncology Reports · doi:10.3892/or.2021.8147 · Cited by 5
Čuperlović‐Culf, M., Belacel, N., Davey, M., & Ouellette, R. J. (2010) · Biomarkers · doi:10.3109/1354750x.2010.511268 · Cited by 5
Message passing algorithms for dirichlet diffusion trees
Knowles, D. A., Gael, J. V., & Ghahramani, Z. (2011) · Cited by 5
Gu, Y. J., Chow, M. J., Kapoor, A., Lin, X., Mei, W., & Tang, D. (2021) · Genes · doi:10.3390/genes12020257 · Cited by 5
PlexinD1 is a driver and a therapeutic target in advanced prostate cancer
Wei, J., Wang, J., Guan, W., Li, J., Pu, T., Corey, E., Lin, T.-P., Gao, A. C., & Wu, B. J. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00186-z · Cited by 5
Multi-Omics Analysis of Primary Prostate Cancer Datasets Reveals Novel Biomarkers
Tuncer, M., Karabekmez, M. E., & Collak, F. K. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10899-y · Cited by 4
Clinical Evaluation of FOXO1 as a Tumor Suppressor in Prostate Cancer
Yang, N., Wu, J., Zhang, T., Yang, F., Shao, J., He, C., & Qin, L. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/8773423 · Cited by 4
Eshun, R. B., Islam, A. K. M. K., & Bikdash, M. U. (2021) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc46164.2021.9630460 · Cited by 4
Bhusari, S. S., Yang, B., Huang, W., & Jarrard, D. F. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.02.1695 · Cited by 4
The tissue microarray OWL schema: An open-source tool for sharing tissue microarray data
Kang, H. P., Borromeo, C. D., Berman, J. J., & Becich, M. J. (2010) · Journal of Pathology Informatics · doi:10.4103/2153-3539.65347 · Cited by 4
Self-citationJadamba, E., Cho, S. B., & Shin, M. (2015) · BioChip Journal · doi:10.1007/s13206-015-9407-9 · Cited by 4
Prognostic role of TPL2 in early-stage non-small cell lung cancer
Boldrini, L., Giordano, M., Servadio, A., Niccoli, C., Bertoglio, P., Lucchi, M., Melfi, F. M. A., Mussi, A., & Fontanini, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6430 · Cited by 6
Identifizierung und Validierung klinisch relevanter molekularer Veränderungen im Prostatakarzinom
Schlomm, T., Sültmann, H., & Köllermann, J. W. (2008) · Der Urologe · doi:10.1007/s00120-008-1834-y · Cited by 3
Wang, W., Liu, J.-J., Li, Y., Ko, S., Feng, N., Zhang, M., Lin, Q., Xia, M., Yu, Y. P., Luo, J.-H., et al. (2026) · Genome biology · doi:10.1186/s13059-026-04023-z · Cited by 3
Self-citationGenomic predictors of prostate cancer therapy outcomes
Lewinshtein, D. J., Porter, C. R., & Nelson, P. S. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.53 · Cited by 3
You, H. J., You, B.-C., Kim, J.-K., Park, J. M., Song, B.-S., & Myung, J. (2021) · Biomedicines · doi:10.3390/biomedicines9101404 · Cited by 3
Li, Q., Eklund, A. C., Birkbak, N. J., Desmedt, C., Haibe‐Kains, B., Sotiriou, C. P., Symmans, W. F., Pusztai, L., Brunak, S., Richardson, A. L., et al. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-310 · Cited by 3
Malins, D. C. (2004) · Cell Cycle · doi:10.4161/cc.3.10.1169 · Cited by 3
Collins, S., McRae, D. A., Gagnon, G. A., & Dritschilo, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-079-3_15 · Cited by 3
Liu, Y., Song, H., Pan, J., & Zhao, J. Y. (2015) · Journal of Applied Genetics · doi:10.1007/s13353-015-0313-6 · Cited by 3
Sekino, Y., Li, H.-T., Kaneko, M., Inoue, Y., Ramacciotti, L. S., Lu, R., Deng, Z., Zhou, X., Song, M. M., Desai, A., et al. (2026) · Biomarker Research · doi:10.1186/s40364-026-00890-7 · Cited by 2
Metadata
- Authors
- Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., Michalopoulos, G., Becich, M., & Luo, J.-H.
- Affiliations
- University of Pittsburgh (US)
- From the Department of Pathology and Urology, University of Pittsburgh School of Medicine, and Biostatistics Center, University of Pittsburgh Cancer Institute and Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2004-07-15
- Volume
- 22
- Issue
- 14
- Pages
- 2790-2799
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2108426942
- Semantic Scholar
- 8be3bd0e253d2a736b72002f40143dec896e862a
- Cited by
- 758
- References
- 23
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 31 · 2023: 31 · 2022: 20 · 2021: 30 · 2020: 26 · 2019: 29 · 2018: 29 · 2017: 38 · 2016: 24 · 2015: 47 · 2014: 58 · 2013: 41 · 2012: 47
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (U01CA088110, 1U01 CA 88110-01, R01CA098249)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- prostate cancer, gene expression profiling, tumor aggressiveness, prostate carcinogenesis, gene expression patterns
- MeSH terms
- Adult, Cell Transformation, Neoplastic, Humans, Male, Middle Aged, Neoplasm Invasiveness, Predictive Value of Tests, Prostate, Prostatic Neoplasms, Gene Expression, Disease Progression, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.